Dr Hendrik-Tobias Arkenau, Consultant Medical Oncologist
Dr Hendrik-Tobias Arkenau
Consultant Medical Oncologist
Dr Hendrik-Tobias Arkenau MD PhD
Consultant Medical Oncologist
Dr Hendrik-Tobias Arkenau
Consultant Medical Oncologist MD PhD
Dr Arkenau is a Consultant Medical Oncologist
Areas of expertise
- Stomach cancer
- Melanoma
- Liver cancer
- Pancreatic cancer
- Bowel cancer
Make an appointment
Address
-
HCA UK at University College Hospital
Grafton Way Building, 1 Grafton Way, London, WC1E 6AG
-
LOC at Chelsea
102 Sydney Street, Chelsea, London, SW3 6NJ
-
LOC - Leaders in Oncology Care
95-97 Harley Street, London, W1G 6AF
-
Sydney Street Outpatients and Diagnostics Centre
102 Sydney Street, London, SW3 6NJ
-
The Harley Street Clinic
35 Weymouth Street, London, W1G 8BJ
-
The Wellington Hospital
Wellington Place, St John's Wood, London, NW8 9LE
About Dr Hendrik-Tobias Arkenau
GMC number: 6094830
Year qualified: 2000
Place of primary qualification: Medizinische Hochschule Hannover
Professor Tobias Arkenau is a highly-respected Consultant Medical Oncologist who works at several HCA Healthcare locations, including the Sarah Cannon Research Institute, The Harley Street Clinic, The Princess Grace, and The Wellington Hospital. He also holds an NHS post at University College London Hospital, where he is a Professorial Research Associate.
Professor Arkenau was awarded his medical degree from Hanover Medical School in Germany in 2000. Following this, he completed specialist training in oncology across several centres of excellence, including the Royal Marsden Hospital. He was granted a Fellowship by the Royal College of Physicians and is highly regarded for his research contributions to the fields of gastrointestinal cancers, drug development, and immunotherapy.
As one of the founding Medical Directors of the Sarah Cannon Research Institute UK, Professor Arkenau currently serves as Executive Medical Director for SCRI UK. He also holds the role of Clinical Lead for the HCA Healthcare UK Cancer Service Line. This highly skilled physician has extensive experience in treating various types of cancers, primarily gastrointestinal and skin cancers.
Throughout his career, Professor Arkenau has published numerous peer-reviewed articles and book chapters. He regularly presents at international conferences such as ASCO, ESMO, and AACR. He currently leads the Sarah Cannon Institute UK as Chief Investigator for several clinical trials involving new anti-cancer treatments, including immunotherapy and cellular therapy.
Diseases, Medical Tests, and Treatments
- Immunotherapy
- Chemotherapy
- Clinical Trials, Phase-1 studies
- Drug Development, Experimental Therapies
- TIL-Therapy
- Biological Therapy
- Video Consultation
- Genetic Testing (Genomics Review Board)
- Gastrointestinal Cancer
- Skin Cancer
- Upper Gastrointestinal Cancer
- Lower Gastrointestinal Cancer
- Melanoma
- Bile Duct Cancer
- Bowel Cancer
- Colon Cancer
- Gallbladder Cancer
- Liver Cancer
- Oesophagus Cancer
- Pancreatic Cancer
- Stomach Cancer
- Small Bowel Cancer
Professor Arkenau's dedication to advancing cancer treatment and his commitment to patient care make him a leading figure in the field of medical oncology.
Areas of expertise
- Gastro-intestinal
- Melanoma
- Liver cancer
- Medical Oncologist
Professional memberships
Articles by Dr Hendrik-Tobias Arkenau
Phase i/iia, open-label, multicentre study to evaluate the optimal dosing and safety of odm-203 in patients with advanced or metastatic solid tumours
health-related quality of life associated with trifluridine/tipiracil in heavily pretreated metastatic gastric cancer: results from tags
Esmo clinical research observatory (ecro): improving the efficiency of clinical research through rationalisation of bureaucracy
Mammographic breast density and urbanization: interactions with bmi, environmental, lifestyle, and other patient factors
Recent progress in the systemic treatment of advanced/metastatic cholangiocarcinoma
Immunogenomic profile of colorectal cancer response to immune checkpoint blockade
